Classification
Product TypeIngredient
Product FormConcentrated extract
Industry PositionBotanical extract ingredient (dietary supplement and functional food formulations)
Market
Concentrated ginseng extract in Mexico is primarily an import-oriented ingredient market, with demand concentrated in downstream dietary supplement and functional formulation uses rather than primary agricultural production. Mexico’s health authority (COFEPRIS) defines dietary supplements as products based on herbs and plant extracts and distinguishes them from medicines, with explicit limits on therapeutic positioning. When imported as a dietary supplement product, COFEPRIS indicates it requires a Permiso Sanitario Previo de Importación (PSPI) and reviews labeling and ingredients as part of the permit process. For customs/tariff handling, ginseng extracts are commonly treated within the broader “vegetable saps and extracts” HS heading (13.02), but the exact tariff fraction and regulatory pathway depend on product presentation and intended use.
Market RoleNet importer / import-dependent ingredient and consumer market
Domestic RoleDownstream formulation and retail market (supplements/functional products) relying on imported ginseng extract inputs
Market Growth
Risks
Regulatory Compliance HighMisclassification or incomplete COFEPRIS compliance for imported ginseng-extract products marketed as dietary supplements can block entry or delay clearance, because COFEPRIS indicates supplements require a Permiso Sanitario Previo de Importación (PSPI) and the authority reviews ingredients and labeling as part of the permit process; non-compliant therapeutic positioning is explicitly restricted.Run a pre-import classification decision (supplement vs other category), prepare a PSPI-ready dossier (ingredient composition + Spanish labeling/contraetiqueta), and align the permit data with the pedimento and transmitted annex documents.
Labeling And Claims MediumMarketing claims that imply prevention/treatment/cure can shift the product into a regulated “medicine/insumo para la salud” posture or trigger enforcement, since COFEPRIS frames supplements as non-medicinal and Mexican framework requires “Este producto no es un medicamento” when presentation suggests therapeutic properties.Constrain claims to dietary supplementation language; ensure required legends/disclaimers and labeling elements match the applicable Mexican framework for the specific product category.
Quality And Adulteration MediumBotanical extracts carry elevated authenticity and potency-variance risk; inconsistent ginsenoside profiles or substitution can create customer complaints, recalls, or regulatory scrutiny (especially when potency-standardized claims are made).Implement supplier qualification and incoming QA using recognized monograph-style tests/specifications (e.g., total ginsenosides for the declared Panax species) and retain batch COAs and retain samples.
Documentation Gap MediumIncomplete or inconsistent digital annex documentation linked to the pedimento (invoice/value data and transport documents, among others) can slow customs processing or trigger requests for originals.Use a customs broker checklist aligned to ANAM/SAT guidance for pedimento annex e-documents and ensure consistent product description/HS fraction across invoice, permit documents (if any), and COA.
Sustainability- Wild-harvest sustainability risk is a known concern for American ginseng (Panax quinquefolius), historically linked to overharvest pressures; importers may face reputational and sourcing-risk exposure if supply is not demonstrably legal and sustainable.
FAQ
Does Mexico require a sanitary import permit for ginseng extract products sold as dietary supplements?COFEPRIS states that dietary supplements require a Permiso Sanitario Previo de Importación (PSPI) and that the authority reviews the product’s labeling and ingredients as part of granting the permit. Whether your ginseng extract shipment is treated as a supplement (and therefore follows this pathway) depends on the product presentation and intended use, so classification should be confirmed before shipping.
Can a ginseng-extract supplement in Mexico be marketed with disease-treatment or cure claims?No. COFEPRIS describes dietary supplements as products intended to increase or complement dietary intake and explicitly indicates they are not intended to treat, cure, prevent, or relieve disease. Mexico’s framework also requires the legend “Este producto no es un medicamento” when a product is presented in a way that suggests therapeutic properties.
How is “concentrated ginseng extract” typically specified for quality control in trade?A common approach is to specify the declared Panax species and standardize potency using a total ginsenosides metric. USP monographs provide species-specific definitions and acceptance criteria frameworks for Asian ginseng and American ginseng dry extracts, which many buyers use as reference points for incoming QC and supplier qualification.